Coapt, a developer of prosthetic neural interface technology, is collaborating with Myant, a healthcare textile computing company, to develop and commercialize textile-based electromyography (EMG) interfaces, enhancing the way prosthetic limbs and related therapeutic devices interact with the human body.
In merging Coapt’s EMG intent decoder control systems with Myant’s textile technologies, the collaboration seeks to bring forward new products for people who use prosthetic limbs. The companies say that products born from the partnership may open new pathways for therapies that target phantom limb pain and biofeedback-based solutions.
Myant and Coapt will explore virtual and augmented reality applications for medical therapies and include funded research and clinical trials.
“Together, Coapt and Myant are creating a future where assistive technology not only helps people regain function, but also improves their overall comfort and autonomy,” said Coapt CEO Blair Lock.
